Hiroya Kobayashi
- Immunology top 1%
- Immunotherapy and Immune Responses 41
- Immune Cell Function and Interaction 24
- T-cell and B-cell Immunology 14
- Immune cells in cancer 10
- interferon and immune responses 8
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers 15
- CAR-T cell therapy research 14
- Immunology and Allergy top 10%
- Molecular Biology top 10%
- vaccines and immunoinformatics approaches 12
- Pathology and Forensic Medicine top 10%
Hiroya Kobayashi
87 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 99
- Immunology 1.7k
- Oncology 1.0k
- Immunology and Allergy 77
- Molecular Biology 844
- Pathology and Forensic Medicine 219
Countries citing papers authored by Hiroya Kobayashi
This map shows the geographic impact of Hiroya Kobayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroya Kobayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroya Kobayashi more than expected).
Fields of papers citing papers by Hiroya Kobayashi
This network shows the impact of papers produced by Hiroya Kobayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroya Kobayashi. The network helps show where Hiroya Kobayashi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hiroya Kobayashi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2023 | 3 | |
| 4 | 2022 | 4 | |
| 5 | 2022 | 12 | |
| 6 | 2022 | 8 | |
| 7 | 2022 | 23 | |
| 8 | 2021 | 44 | |
| 9 | 2021 | 11 | |
| 10 | 2020 | 19 | |
| 11 | 2019 | 19 | |
| 12 | 2018 | 10 | |
| 13 | 2016 | 57 | |
| 14 | 2011 | 27 | |
| 15 | 2008 | 35 | |
| 16 | 2007 | 28 | |
| 17 | 2007 | 17 | |
| 18 | 2004 | 35 | |
| 19 | Defining promiscuous MHC class II helper T-cell epitopes for the HER2/neu tumor antigen. | 2000 | 121 |
| 20 | 2000 | 10 |
About Hiroya Kobayashi
Hiroya Kobayashi is a scholar working on Immunology, Oncology and Immunology and Allergy, having authored 88 papers that have together received 2.3k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (41 papers), Immune Cell Function and Interaction (24 papers), Cancer Immunotherapy and Biomarkers (15 papers), CAR-T cell therapy research (14 papers), T-cell and B-cell Immunology (14 papers), vaccines and immunoinformatics approaches (12 papers), Immune cells in cancer (10 papers) and interferon and immune responses (8 papers). The work is most often cited by research in Immunology (1.7k citations), Oncology (1.0k citations) and Immunology and Allergy (77 citations). Hiroya Kobayashi has collaborated with scholars based in Japan, United States and Spain. Frequent co-authors include Esteban Celis, Yasuaki Harabuchi, Takumi Kumai, Naoko Aoki, Shoji Kimura, Toshihiro Nagato, Kensuke Oikawa, Keisuke Sato, Takayuki Ohkuri and Masatoshi Tateno. Their work appears in journals such as Cancer Immunology Immunotherapy, Clinical Cancer Research, Immunogenetics, OncoImmunology and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.